Nanjing Well Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 5/6
Nanjing Well Pharmaceutical GroupLtd has a total shareholder equity of CN¥1.6B and total debt of CN¥446.4M, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are CN¥2.3B and CN¥660.6M respectively. Nanjing Well Pharmaceutical GroupLtd's EBIT is CN¥140.1M making its interest coverage ratio 9.7. It has cash and short-term investments of CN¥148.1M.
Key information
27.4%
Debt to equity ratio
CN¥446.38m
Debt
Interest coverage ratio | 9.7x |
Cash | CN¥148.14m |
Equity | CN¥1.63b |
Total liabilities | CN¥660.59m |
Total assets | CN¥2.29b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603351's short term assets (CN¥626.2M) exceed its short term liabilities (CN¥533.6M).
Long Term Liabilities: 603351's short term assets (CN¥626.2M) exceed its long term liabilities (CN¥127.0M).
Debt to Equity History and Analysis
Debt Level: 603351's net debt to equity ratio (18.3%) is considered satisfactory.
Reducing Debt: 603351's debt to equity ratio has increased from 8.1% to 27.4% over the past 5 years.
Debt Coverage: 603351's debt is well covered by operating cash flow (36.4%).
Interest Coverage: 603351's interest payments on its debt are well covered by EBIT (9.7x coverage).